CIO 2023
CIO 2023
Advertisement
Rob DillardCIO 2023 | September 28, 2023
Histotripsy is an innovative modality for treating liver tumors that offers several advantages.
Read More
Rob DillardCIO 2023 | September 28, 2023
The number of arteries treated during transarterial chemoembolization did not affect outcomes in liver cancer patients.
Rob DillardCIO 2023 | September 28, 2023
Radiation lobectomy with transarterial embolization of Yttrium-90 is a viable option for hepatocellular carcinoma.
Rob DillardCIO 2023 | September 28, 2023
Durvalumab plus tremelimumab significantly improved overall survival in patients with unresectable liver cancer.
Advertisement
Advertisement
Advertisement
Latest News

March 13, 2025